What does EBARA JITSUGYO do?
EBARA JITSUGYO sells engineering, equipment and proprietary products that clean water, air and waste for Japan's cities and factories. The company runs three businesses. Its Engineering business wins water and sewerage plant orders directly from municipalities, then designs and builds the plant. Its Trading business resells pumps, blowers and air-conditioning equipment made by EBARA Corporation. Its Manufacturing business sells products the company develops itself, such as ozone systems, deodorization equipment and storage batteries.
The company is paid mainly by project. Each Engineering and Manufacturing order is won, built and billed, so revenue depends on the orders the company is working through. The Trading business adds steady repeat sales as customers reorder equipment. There is little pure recurring revenue, so the order backlog is how the company shows investors its future workload.
The business matters because Japan must renew aging water and sewerage infrastructure and cut carbon for decades, and EBARA JITSUGYO designs the plant that does this work. In FY12/25 the company earned ¥41.21bn of revenue and ¥6.12bn of operating profit (OP), a 14.9% group OP margin. It carries net cash and needs little capital to operate, so ROCE was about 22%, a measure of how well the operating business turns the capital it uses into profit.
The stock does not reflect that quality. At ¥2,446 on June 30, 2026, the operating business was valued at about 7.2x forward EV/OP — and only about 5.8x on a Core EV/OP (cEV/OP) basis, which also strips out the ¥9.35bn of investment securities the company holds. Net cash equaled roughly 21% of the market value. The question is why investors apply a single-digit multiple to a net-cash company with a 22% ROCE, a record backlog, and an activist investor on its share register. This profile answers that in four steps: how the share price reached this level, what investors are debating, what management could do to narrow the discount, and what the business and the cash are worth.
What has driven the stock over the past two years?
EBARA JITSUGYO designs and builds water and sewerage plant for Japan's municipalities, resells EBARA Corporation pumps and air equipment, and makes its own environmental products. It wins most work by direct order from the public sector, so its order backlog measures the workload it has already secured.
01 · When investors paid up for the record year The shares reached ¥2,960 on February 27, 2026, valuing the operating business at about 9–10x EV/OP. The move followed a run of good news. On February 9, 2026 the company reported record FY12/25 results, with OP up 44.0% YoY, authorized a ¥1.0bn buyback, and raised its payout target. A week later news that an activist had filed shareholder proposals added to the optimism. Investors were paying for a record year and the prospect of more cash being returned.
02 · When the multiple fell back From the peak the shares fell about 17% to a low of ¥2,259 on June 3, 2026. Two things drove the de-rating. First, small-cap and value stocks were sold across Tokyo through the 2Q, and EBARA JITSUGYO trades thinly. Second, the activist's three proposals were rejected at the March 24, 2026 annual meeting, which told the market that minority holders could not force the cash off the balance sheet. The multiple compressed even though earnings did not fall.
03 · When the 1Q print and the buyback landed On May 11, 2026 the company reported its 1Q for FY12/26, with OP up 15.9% YoY and the order backlog up 19.6% YoY to ¥32.77bn — a record. The buyback was running underneath the price: by June 4, 2026 the company had purchased 289,000 of the authorized 600,000 shares for ¥730.9mn, and on July 10, 2026 the company announced the program had completed at 402,900 shares for ¥999.9mn. The operating numbers kept improving while the share price stayed near its low.
04 · Where the stock stands now The stock closed at ¥2,446 on June 30, 2026 — up about 8% off the June low and about 17% below the February peak. The shares traded at roughly 7.2x forward EV/OP. Net cash is worth 21% of the market value, the order backlog is at a record, the ¥1.0bn buyback completed on July 10, 2026 (402,900 shares for ¥999.9mn — effectively the full authorization), and the activist remains on the share register. The next four quarters depend mainly on one question — whether management deploys the cash and discloses a clearer capital framework, or whether the discount holds.
Live Investor Debates
Three investor debates explain the single-digit multiple. They appear in the company's disclosures, the share-price decline, and the gap between the quality of the business and its valuation.
Standard EV/OP removes only net cash, so 7.2x is one read. Strip the ¥9.35bn of investment securities as well — the Core EV/OP (cEV/OP) — and the operating business is priced at about 5.8x. The debate is whether that is too cheap for a 22% ROCE business, or whether the idle cash and securities deserve a discount.
The company books an order, then converts it to revenue as it builds. Order backlog of ¥32.77bn is the work already won. The debate is whether that backlog reflects a steady pipeline of infrastructure renewal, or whether a few large one-off contracts make the growth look more durable than it is.
To cement its role as EBARA Corporation's authorized distributor, the company holds 1,095,788 EBARA (6361) shares — worth about ¥6.86bn at the latest close, or roughly 15% of enterprise value. EBARA holds just 0.24% of the company back, and none as a reciprocal cross-holding. The capital tie runs one way.
A note on the 1Q order jump. The 1Q order surge of 40.5% did not come from the core Engineering business. It came from Manufacturing, where orders rose 281.9% YoY on a single large land-based aquaculture water-treatment facility plus medical hygiene equipment for government buyers. Engineering orders actually fell 4.1% YoY, and its sales held up only on the existing backlog. So the headline order growth is a one-off, not a durable increase in the core run-rate.
Capital-Efficiency Levers
The multiple could rise even without higher earnings if management reduces the reasons for the current discount. All three changes below depend mainly on management decisions.
Scenario Pathways
At ¥2,446 (June 30, 2026), an enterprise value of ~¥45.7bn against FY12/26 OP guidance of ¥6.3bn implies about 7.2x forward EV/OP — or about 5.8x on Core EV/OP (cEV/OP), which also removes the ¥9.35bn of investment securities. The three scenarios below are JII estimates, not company guidance.
- Cash and securities stay idle; no new capital framework.
- The activist loses again at the next vote.
- Backlog normalizes as the one-off order rolls off.
- Thin liquidity keeps small-cap demand weak.
Even here, net cash limits the downside: it is worth ~21% of the current market value, a cushion that would matter in any strategic valuation.
- Buyback continues and the payout target of 40% holds.
- ROCE holds near 20% as the backlog converts.
- One capital-efficiency step: cross-holding run-off or framework.
- EV/OP widens toward the high-single digits.
- Cash and securities are deployed into returns or growth.
- The multiple re-rates toward the water-treatment band.
- Backlog conversion plus acquisitions support the FY12/30 vision.
- Net cash falls as buybacks accelerate.
The implied fundamental value could be higher: the sum-of-parts below points to ¥2,940–4,000 if investors give the cash and the cross-holding close to full value.
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion. JII does not have an investment opinion on any security discussed.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Conflicts & positions. JII may provide paid IR translation, interpretation, English-review, or consultation services to Japanese listed companies, including companies discussed in this publication. JII does not trade in or hold positions in the securities of companies profiled. Where a JII engagement exists with a profiled company, that fact will be disclosed at the top of the profile.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。